A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors

被引：0
|
作者：
Laura Q. M. Chow
S. Gail Eckhardt
Cindy L. O’Bryant
Mary Kay Schultz
Mark Morrow
Stacy Grolnic
Michele Basche
Lia Gore
机构：
[1] University of Colorado Cancer Center,
[2] The Children’s Hospital,undefined
[3] University of Colorado Health Sciences Center at Fitzsimons,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Lonafarnib; SCH66336; Cisplatin; Gemcitabine; Farnesyltransferase; Phase I; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：631 / 646
页数：15
相关论文
共 50 条
  • [21] A phase I study of NC-6004, a micellar formulation of cisplatin, in combination with gemcitabine in Japanese patients with advanced solid tumors
    Hamaguchi, Tetsuya
    Doi, Toshihiko
    Shitara, Kohei
    Iwasa, Satoru
    Shimada, Yasuhiro
    Harda, Mitsunori
    Naito, Kenichiro
    Hayashi, Naoto
    Masada, Atsuhiro
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors
    Ready, Neal E.
    Lipton, Alan
    Zhu, Yali
    Statkevich, Paul
    Frank, Emily
    Curtis, Dolores
    Bukowski, Ronald M.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 576 - 583
  • [23] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    William Schelman
    Sherry Morgan-Meadows
    Howard Bailey
    Kyle Holen
    James P. Thomas
    Jens Eickhoff
    Heidi Brandon
    Kate Oliver
    Dona Alberti
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 727 - 733
  • [24] A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
    Schelman, William
    Morgan-Meadows, Sherry
    Bailey, Howard
    Holen, Kyle
    Thomas, James P.
    Eickhoff, Jens
    Brandon, Heidi
    Oliver, Kate
    Alberti, Dona
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (04) : 727 - 733
  • [25] Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report
    Mavroudis, D
    Kourousis, C
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Androulakis, N
    Souglakos, J
    Vardakis, N
    Samonis, G
    Georgoulias, V
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 25 - 30
  • [26] Phase I study of E7389/gemcitabine combination in patients with advanced solid tumors
    Goel, R.
    Chen, E.
    Welch, S.
    Laurie, S.
    Siu, L.
    Jonker, D.
    Srinivasan, R.
    Wang, L.
    Ivy, P.
    Oza, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Phase I study of Mistletoe extract/gemcitabine combination treatment in patients with advanced solid tumors
    Mansky, P.
    Wallerstedt, D.
    Monahan, B.
    Lee, C.
    Sannes, T.
    Stagl, J.
    Blackman, M.
    Swain, S.
    Grem, J.
    ONKOLOGIE, 2008, 31 : 200 - 200
  • [28] Phase I study of pan-histone deacetylase inhibitor abexinostat in combination with cisplatin in patients with advanced solid tumors
    Campone, M.
    Isambert, N.
    Sabatier, R.
    Castanie, H.
    Zanetta, S.
    Sudey, I.
    Cantero, F.
    Pauly, J.
    Leroux, E.
    Malasse, S.
    Goncalves, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 189 - 189
  • [29] Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors
    Duran, I
    Siu, LL
    Chen, EX
    Oza, AM
    Sturgeon, J
    Chin, SF
    Brown, S
    Pond, GR
    Nottage, M
    ANTI-CANCER DRUGS, 2006, 17 (01) : 81 - 87
  • [30] Pemetrexed combined with gemcitabine and cisplatin:: a phase I study in patients with locally advanced or metastatic solid tumors
    Graefe, T.
    Luebbing, C.
    Bolling, C.
    Yilmaz, E.
    Fleeth, J.
    Luedtke, F. E.
    Mueller-Hagen, S.
    Depenbrock, H.
    Ohnmacht, U.
    Hanauske, A.-R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 432 - 432
12345